STUB1 and Stroke: Other studies have identified DNMT3A (30.0%) and TET2 (11.4%) as the most common mutations in individuals with CHIP who experienced a first-ever acute ischemic stroke, and CHIP was specifically associated with recurrent stroke in patients with hyperinflammation (56).